Xu, Xin <br/><br/>
Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells.  [electronic resource] 

 -  International journal of cancer  01 2020 
 - 400-412 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.32552  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--chemistry<br/>Apoptosis--drug effects<br/>Bone Marrow--pathology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>DNA Demethylation--drug effects<br/>DNA Methylation--drug effects<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Female<br/>Histones--metabolism<br/>Humans<br/>Jumonji Domain-Containing Histone Demethylases--antagonists & inhibitors<br/>Leukemia, Biphenotypic, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Molecular Docking Simulation<br/>Oxidoreductases, N-Demethylating--antagonists & inhibitors<br/>Protein Domains<br/>Structure-Activity Relationship<br/>Surface Plasmon Resonance<br/>Tretinoin--pharmacology